Although Long COVID continues to be a mystery, we are slowly beginning to understand more about the disease as new research has identified antibodies associated with Long COVID symptoms.

A Stanford Medicine study recently uncovered a new molecular link between gluten exposure and intestinal damage.

For patients with autoimmune encephalitis, the onset of disease can be very rapid, occurring over a few days, or more slowly over the course of weeks to months. If left untreated, the disease can quickly become serious and lead to coma or permanent brain injury.

Over 1.5 million people in the U.S. are affected by lupus, and the cause of this autoimmune disease remains unclear. However, the latest discovery of what may be the cause of lupus could potentially lead to new treatments that can reverse the disease.

Previous research on people with primary Sjögren’s (pSS) linked changes in one's oral microbiome to low salivary secretion, however, few studies analyze the relationship between oral microbiome and dental caries in those with pSS.

While studying a 67-year-old woman with symptoms of unsteadiness (ataxia), tremors, and difficulty speaking, researchers identified an autoantibody that causes B12 deficiency in the brain and results in neurological symptoms.

Researchers at the Francis Crick Institute, University College London, and Imperial College London have identified a new biological pathway critical in driving inflammatory bowel disease (IBD) and other related conditions such as Crohn's disease and ulcerative colitis.

We welcome our newest network member, Living with IgG4-Related Diseases, a global and private Facebook group with over 2,400 members of which the majority are patients, caregivers, and allies.

Alopecia areata (AA) is an autoimmune disease that mistakenly attacks hair follicles and leads to hair loss. It affects nearly 7 million people in the United States.

In autoimmune diseases, many conditions share similar symptoms as well as similar treatments. Off-label drugs are often used to treat autoimmune diseases for which they were not originally approved.

In one of our previous newsletters, we discussed the psychological and neurological impacts of autoimmune diseases, in that some patients with autoimmune conditions like lupus and rheumatoid arthritis may experience neurological conditions that tend to be overlooked.

Artificial intelligence (AI) has become a major force in healthcare by revolutionizing the practice of medicine and how people are treated.

In honor of Lupus Awareness Month, we wanted to share Emmitt Henderson III's story, whose journey is a testament to the resilience of the human spirit.

May is Lupus Awareness Month! Help raise awareness to support early diagnosis and proper disease management for patients. With advocacy and awareness, more funding can go toward the research of new drugs and treatments to improve patient outcomes.

In a recent discovery, UC San Francisco (UCSF) scientists have found a revolutionary method for identifying early biomarkers for multiple sclerosis (MS).

One of the Autoimmune Registry's goals is to increase awareness of autoimmune diseases to improve existing treatment protocols and disease management strategies. Clinical trials are a crucial part of testing new treatments and participation is important to ensure that new medications are approved for the public.

Although there are various treatment options for autoimmune disease, researchers are always looking to develop the next best treatment. Scientists at Mayo Clinic have developed an innovative immunotherapy approach that could revolutionize autoimmune disease treatment.

Once thought to be a rare disease, Sjogren's is now recognized as one of the most prevalent autoimmune diseases, affecting an estimated 1 to 4 million people in the United States.

Autoimmune diseases are notorious for their lengthy diagnostic process. Patients often suffer for years without a diagnosis or are misdiagnosed, leading to delays in proper treatment.